Elon Musk Calls This "The Greatest Company in Europe"

ASML is highlighted as a critical supplier of extreme ultraviolet photolithography machines, with a roughly $730 billion market cap, 33 billion euros in annual sales, 54% revenue growth over three years, and margins near 30%. Elon Musk called it "arguably the greatest company in Europe," reinforcing the company’s strategic importance to AI and advanced-chip manufacturing. The article is broadly positive on ASML’s long-term outlook, though it notes the stock trades at more than 60x trailing earnings.

Analysis

The market is still underappreciating that ASML is not just a high-quality equipment vendor; it is the gating item for the entire leading-edge compute stack. That creates a second-order benefit for capital allocators upstream and downstream: every incremental wafer fab announcement tied to AI, HBM, or advanced logic tends to pull forward ASML demand with little substitution risk, while forcing rivals to compete on node access rather than pure product differentiation. In that sense, ASML is a toll collector on the arms race, and the real sensitivity is less to near-term chip cycle noise than to whether capex stays elevated for 3-5 years.

The bigger setup is that AI infrastructure spending is becoming more concentrated in a handful of strategic bottlenecks, and lithography is one of the hardest to de-risk. That supports a long-duration earnings compounding story, but it also means consensus can overextrapolate margin durability: if a few large customers pause tool installs for one budget cycle, the multiple can compress faster than earnings can re-rate. The most likely disappointment is not demand collapse but timing slippage, which matters because the stock is already pricing in a lot of the good news.

For the rest of the semis complex, ASML strength is a positive read-through for NVDA and, to a lesser extent, INTC, but the dispersion matters. NVDA benefits if leading-edge capacity expands smoothly; INTC benefits only if its foundry ambitions keep attracting external wafer demand, which is a much lower-probability path. TSLA is a weak indirect beneficiary at best: any future in-house chip initiative still relies on the same ecosystem, but that is a multi-year story and not a near-term trade catalyst.

The contrarian miss is that ASML’s moat is real, but the stock can still be too good a business at too full a valuation when the market is paying up for certainty. If sentiment rotates away from mega-cap AI winners, ASML can underperform fundamentals for months even without any change in order quality. The cleanest risk is macro-driven capex digestion, while the cleanest upside catalyst is another wave of sovereign/industrial AI spend that forces fab investment to re-accelerate.

Key Decisions for Investors

• Stay long ASML on pullbacks, but only add on 5-8% drawdowns; risk/reward is best when the market is pricing a capex pause rather than perpetual acceleration.
• Pair long ASML / short a basket of lower-quality semi capex proxies for 3-6 months; thesis is that the scarce bottleneck wins while commoditized suppliers are more exposed to timing slippage.
• Use NVDA strength as confirmation, not a substitute: long NVDA vs short INTC on a 3-9 month horizon, since ASML-led capacity expansion helps NVDA monetization more reliably than it helps Intel’s turnaround.
• If ASML gaps higher on headline enthusiasm, sell upside via covered calls 1-2 quarters out; valuation risk is more likely to come from multiple compression than from fundamental deterioration.
• Avoid chasing TSLA on this narrative; any benefit is too remote. If owned, treat it as an unrelated position and do not add based on ASML linkage.